Market News & Trends
Immune Design & Gritstone Oncology Announce Clinical Collaboration
Immune Design and Gritstone Oncology recently announced a clinical collaboration for development of novel, personalized immunotherapies combining both companies’ leading technologies. The collaboration will involve…
Alize Pharma II Acquired by Jazz Pharmaceuticals
Alizé Pharma II recently announced that a subsidiary of Jazz Pharmaceuticals plc has acquired 100% of its shares. This all-cash transaction closed in March 2016.…
Ajinomoto Althea, Inc. Announces Issuance of New US Patent for Manufacturing of Crystal Monoclonal Antibodies
SAN DIEGO, CA, May 17, 2016 -- Ajinomoto Althea Inc., a leading provider of biotherapeutic contract development and manufacturing services, today announced that the United…
Vifor Pharma Licenses Rights to Commercialize ChemoCentryx’s Orally Administered Complement 5aR Inhibitor
Vifor Pharma and ChemoCentryx, Inc. recently announced that Vifor Pharma has licensed rights to commercialize CCX168, a Complement 5a Receptor (C5aR) inhibitor ready for Phase…
Capsugel Expands Micro-Dosing Services to Help Accelerate Customers' Product Development Timelines
Morristown, N.J., May 16, 2016 – Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced that it is expanding its…
Aptar Pharma's Preservative-Free Multi-Dose Ophthalmic Squeeze Dispenser Launched in US
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, has partnered with…
Dublin-Based Innopharma Technology Announces Strategic Collaboration With Glatt
Dublin-based Innopharma Technology and Glatt (India) Systems Pvt. Ltd. have recently announced a strategic collaboration that is set to reduce product manufacturing costs…
Disease-Modifying Drugs Will Propel Huntington’s Disease Market to $2.6 Billion
The Huntington’s disease market will rise from around $252.6 million in 2014 to over $2.6 billion in 2024, representing a huge Compound Annual Growth Rate…
Opiant Pharmaceuticals' Partner Submits New Drug Submission
Opiant Pharmaceuticals, Inc. recently announced that its commercial partner for naloxone nasal spray for the emergency reversal of opioid overdose, Adapt Pharma Limited, has submitted…
MilliporeSigma Builds on Leading Viral & Gene Therapy Service Offering
MilliporeSigma recently announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products. Scheduled for completion in 2016,…
Merus Announces First Patient Dosed in Phase I/II Trial
Merus B.V. recently announced that the first patient has been dosed in the company’s Phase I/II clinical trial evaluating MCLA-117 as a potential treatment of…
Cellular Immunotherapies Represent Long-Term Opportunity in Immuno-Oncology Space
While cellular immunotherapies, which encompass dendritic cell therapy and chimeric antigen receptor T-cell (CAR-T) therapy, are expected to show promising results in combination treatments in…
CEL-SCI Reports Record Monthly Patient Enrollment for Phase III Head & Neck Cancer Trial
CEL-SCI Corporation recently announced that during the month of April, it has enrolled 41 patients in its ongoing Phase III trial of its investigational immunotherapy…
Alder BioPharmaceuticals Licenses Clazakizumab Rights
Alder BioPharmaceuticals, Inc. and Vitaeris Inc. recently announced that Alder has licensed the exclusive worldwide rights to clazakizumab to Vitaeris. In exchange for the rights…
Meggle Announces New Head of Sales & Marketing
The Business Group Excipients & Technology of MEGGLE announced the appointment of Dr. Albrecht Kraemer, as its new Head of Sales & Marketing as…
Heart Failure Market to Soar to $11.8 Billion by 2025
The heart failure market is set to rise from around $3.2 billion in 2015 to $11.8 billion by 2025, representing a compound annual growth rate…
SERMO Collaborates With Wharton, Google & McKinsey & Company
SERMO recently announced its contribution to Pharma 3D: Rewriting the Script for Marketing in the Digital Age, an eBook released on April 27 by the…
VTU Technology & Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration
VTU Technology, the Austrian protein expression expert announced today the expansion of their global technology collaboration with Boehringer Ingelheim RCV GmbH & Co. KG, a…
Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study
Oasmia Pharmaceutical AB recently announced positive overall survival results for Paclical/Apealea in the Phase III study that included a total of 789 patients with epithelial…
Italy’s Pharmaceutical Industry Value Will Drop to $18.6 Billion by 2020
The pharmaceutical industry in Italy is set to decline from $21.3 billion in 2016 to $18.6 billion by 2020, at a negative compound annual growth…
